{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T05:29:53Z","timestamp":1789622993315,"version":"build-2803163510"},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T00:00:00Z","timestamp":1731974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jphs.2024.11.004","type":"journal-article","created":{"date-parts":[[2024,11,20]],"date-time":"2024-11-20T02:19:01Z","timestamp":1732069141000},"page":"8-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Paclitaxel-induced peripheral neuropathy in male rats attenuated by calmangafodipir, a superoxide dismutase mimetic"],"prefix":"10.1016","volume":"157","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7708-2855","authenticated-orcid":false,"given":"Takehiro","family":"Kawashiri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruna","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mami","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kozo","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumiko","family":"Nagahama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Mine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Koura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takao","family":"Shimazoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jphs.2024.11.004_bib1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/BF02968010","article-title":"Neurotoxicity of taxanes: symptoms and quality of life assessment","volume":"11","author":"Kuroi","year":"2004","journal-title":"Breast Cancer"},{"issue":"28","key":"10.1016\/j.jphs.2024.11.004_bib2","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1200\/JCO.20.01399","article-title":"Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: ASCO guideline update","volume":"38","author":"Loprinzi","year":"2020","journal-title":"J Clin Oncol"},{"issue":"16","key":"10.1016\/j.jphs.2024.11.004_bib3","doi-asserted-by":"crossref","first-page":"8733","DOI":"10.3390\/ijms22168733","article-title":"Preclinical and clinical evidence of therapeutic agents for paclitaxel-induced peripheral neuropathy","volume":"22","author":"Kawashiri","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jphs.2024.11.004_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neuroscience.2016.06.050","article-title":"Oxidative stress in the development, maintenance and resolution of paclitaxel-induced painful neuropathy","volume":"333","author":"Duggett","year":"2016","journal-title":"Neuroscience"},{"issue":"4","key":"10.1016\/j.jphs.2024.11.004_bib5","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.drudis.2014.11.008","article-title":"Calmangafodipir [Ca4Mn(DPDP)5], mangafodipir (MnDPDP) and MnPLED with special reference to their SOD mimetic and therapeutic properties","volume":"20","author":"Karlsson","year":"2015","journal-title":"Drug Discov Today"},{"issue":"7","key":"10.1016\/j.jphs.2024.11.004_bib6","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3390\/antiox9070594","article-title":"Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity","volume":"9","author":"Canta","year":"2020","journal-title":"Antioxidants"},{"issue":"11","key":"10.1016\/j.jphs.2024.11.004_bib7","doi-asserted-by":"crossref","first-page":"669","DOI":"10.3390\/toxics10110669","article-title":"Inhibitory effect of \u03b11 receptor antagonists on paclitaxel-induced peripheral neuropathy in a rodent model and clinical database","volume":"10","author":"Mori","year":"2022","journal-title":"Toxics"},{"issue":"1","key":"10.1016\/j.jphs.2024.11.004_bib8","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1172\/JCI68730","article-title":"Treatment of oxaliplatin-induced peripheral neuropathy by intravenous mangafodipir","volume":"124","author":"Coriat","year":"2014","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.jphs.2024.11.004_bib9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J Neurosci Methods"},{"issue":"1","key":"10.1016\/j.jphs.2024.11.004_bib10","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ejca.2008.10.004","article-title":"Neurotropin reverses paclitaxel-induced neuropathy without affecting anti-tumour efficacy","volume":"45","author":"Kawashiri","year":"2009","journal-title":"Eur J Cancer"},{"issue":"1","key":"10.1016\/j.jphs.2024.11.004_bib11","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1006\/exnr.1995.1008","article-title":"Experimental peripheral neuropathy induced in adult rats by repeated intraperitoneal administration of taxol","volume":"133","author":"Cavaletti","year":"1995","journal-title":"Exp Neurol"},{"issue":"8","key":"10.1016\/j.jphs.2024.11.004_bib12","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1158\/0008-5472.CAN-20-2799","article-title":"Pronociceptive roles of Schwann cell-derived galectin-3 in taxane-induced peripheral neuropathy","volume":"81","author":"Koyanagi","year":"2021","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.jphs.2024.11.004_bib13","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11064-020-03174-0","article-title":"Protective effects of curcumin against paclitaxel-induced spinal cord and sciatic nerve injuries in rats","volume":"46","author":"Yard\u0131m","year":"2021","journal-title":"Neurochem Res"},{"issue":"6","key":"10.1016\/j.jphs.2024.11.004_bib14","doi-asserted-by":"crossref","DOI":"10.1093\/jncics\/pkac075","article-title":"Calmangafodipir for prevention of oxaliplatin-induced peripheral neuropathy: two placebo-controlled, randomized phase 3 studies (POLAR-A\/POLAR-M)","volume":"6","author":"Pfeiffer","year":"2022","journal-title":"JNCI Cancer Spectr"},{"issue":"10","key":"10.1016\/j.jphs.2024.11.004_bib15","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.annonc.2020.07.003","article-title":"Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO-EONS-EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up","volume":"31","author":"Jordan","year":"2020","journal-title":"Ann Oncol"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861324000744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861324000744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T11:50:10Z","timestamp":1734522610000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861324000744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1347861324000744"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2024.11.004","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paclitaxel-induced peripheral neuropathy in male rats attenuated by calmangafodipir, a superoxide dismutase mimetic","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2024.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}